Abstract: Artificial Intelligence (AI) has significantly transformed various industries, including the pharmaceutical sector. As of 2023, the US AI market is valued at $123 billion, with a projection of $594 billion by 2032. Industries such as technology, automotive, finance, and healthcare have seen substantial AI adoption. In healthcare, AI optimizes routine tasks, accelerates drug discovery, and enhances clinical trials and manufacturing processes. However, the increased reliance on AI exposes pharmaceutical companies to cybersecurity threats, including data breaches, intellectual property theft, ransomware, and insider threats. Robust cybersecurity measures, such as strong access controls, securing AI systems, incident response plans, regular security audits, data encryption, employee training, and industry collaboration, are critical. Future trends indicate growing AI investment in healthcare, necessitating continuous advancements in cybersecurity to protect sensitive data and ensure regulatory compliance.

Keywords: Data encryption, AI optimization, Incident response, Cybersecurity, Intellectual property

| DOI: 10.17148/IARJSET.2024.11801